Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir

Annals of Surgery

Volumn 224, Issue 3, 1996, Pages 405-417

  Yang, Li ^a,c   Hwang, Rosa ^a   Pandit, Lalita ^a   Gordon, Erlinda M ^b   French Anderson, W ^a   Parekh, Dilip ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ASCITES; CANCER MORTALITY; CONFERENCE PAPER; CONTROLLED STUDY; EXPRESSION VECTOR; GENE THERAPY; HERPES SIMPLEX; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANIMALS; ANTIVIRAL AGENTS; ASCITIC FLUID; BASE SEQUENCE; GANCICLOVIR; GENE THERAPY; GENETIC VECTORS; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, NUDE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PANCREATIC NEOPLASMS; PERITONEAL NEOPLASMS; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0029794390     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199609000-00017     Document Type: Conference Paper

References (19)

1. Silberberg E, Boring CC, Squines TS. Cancer statistics, 1990. CA Cancer J Clin 1990; 40:9-26.
2. Merrick HW, Dobelhower RR. Aggressive therapy for cancer of the pancreas: does it help? Gastroenterol Clin North Am 1990; 19: 935-962.
3. Klapdor R. Perspectives in chemotherapy of pancreatic cancer. Eur J Surg Oncol 1991 ; 17:153-166.
4. Chen SH, Shine HD, Goodman JC, et al. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer /jiv/vo. Proc Nat Acad Sei U S A 1994;91:3054-3057.
5. Culver K.W, Ram Z, Wallbridge S, et al. In vivo gene transfer with retro viral vector-producer cells for treatment of experimental brain tumors. Science 1992; 256:1550-1552.
6. Special News Report. Gene therapy's growing pains. Science 1995; 269:1051-1055.
7. Cornetta K, Moen RC, Culver K, et al. Amphotropic murine leukemia is not an acute pathogen for primates. Hum Gene Ther 1990; 1:15-30.
8. Muggia FM, Groshen S, Russel C, et al. Intraperitoneal carboplatin and etoposide from persistent epithelial ovarian cancer: analysis of results by prior sensitivity of platinum-based regimens. Gynecol Oncol 1993.
9. Hitoshi K, New-ton PB III, Zhang S, et al. Improved methods of retroviral vector transduction and production of gene therapy. Hum Gene Ther 1994;5:19-28.
10. Lampson LA, Lampson MA, Dünne AD. Exploiting the lacZ reporter gene for quantitative analysis of disseminated tumorgrowth within the brain: use of the lacZ gene product as a tumor antigen, for evaluation of antigenic modulation, and to facilitate image analysis of tumor growth in situ. Cancer Res 1993; 53:176-182.
11. Moolten FL. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm fora prospective cancer control strategy. Cancer Res 1986; 46:5276-5281.
12. Morgan RA, Anderson YVF. Human gene therapy. Ann Rev Biochem 1993:62:119-127.
13. Freeman SM, Abboud CN, Whartcnby KA, et al. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993; 53:5274-5283.
14. Pick J, Barker F, Dazin P, et al. The extent of heterbcellular communication mediated by gap junction is predictive of bystander tumor cytoxicity in vitro. Proc Nail Acad Sei U S A 1995; 92: 11071-11075.
15. Smythc WR, Hwang HC, Elshami AA, et al. Differential sensitivity of thoracic malignant tumors to adenovirus-mediated drug sensitization gene therapy. JThoracCardiovascSurg 1995; 109:626-630.
16. Aoki K, Yoshida T, Sugimura T, Terada M. Liposome-mediated /n v/vo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity. Cancer Res 1995; 55:3810-3816.
17. Gerrit L, Els LME, Mutsaer PHA, McVie JG. Penetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy. Cancer Chemother Pharmacol 1991 ; 28:159-165.
18. Barba D, Hardin J, Sadelin M, Gage FH. Development of antitumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc Nat Acad of Sei USA 1994; 91: 4348-4352.
19. Misawa T, Chiang M, Skotzko M, et al. Development of systemic immunological responses against hepatic métastases during gene therapy of peritoneal carcinomatosis with retroviral HS-tk and ganciclovir. Gastroenterology (abstract for SSAT in press).